CDMO and clinical trial supply firm Experic will open a facility in Dublin, Ireland to support global clinical trials.

Millie Nelson, Editor

February 29, 2024

2 Min Read

New Jersey-based contract development manufacturing organization (CDMO) and clinical trial supply services company for the biopharmaceutical space said its facility in Dublin will support worldwide clinical trials and advance the company’s future growth.

This is Experic’s first expansion of the business into Europe. The 10,000 square-foot warehouse in Dublin will be able to provide customers with monitored storage and logistics services, re-labeling capabilities, and cold storage for quick and reliable distribution of Investigational Medicinal Products (IMPs). Additionally, it will cater for comparators for pharmaceutical firms conducting clinical trials with investigator sites and patients across Europe.

"Experic is a company that listens to its customers,” shared the 25+ year clinical trial supply veteran. “When customers voiced their preference for more clinical trial supply services under the Experic umbrella – we listened - and made it a strategic priority to expand direct management of these services in Europe,” Brian Fagan, vice president of operations at Experic said in a statement.

The firm did not disclose any financials associated with the warehouse, nor did it divulge how many people will be employed at the facility. However, Experic said the activities “will be carried out by local talent that is familiar with EU regulatory requirements,” and will be supported by the company’s US network.

The facility is expected to open in the second half of this year.

Luck of the Irish

Ireland is the world’s third largest pharmaceutical exporter, with over 85 pharma companies operating in the country. Of late, there has been a string of investments in the area with expansions and facility buildouts. This week, Bristol Myers Squibb received planning permission to construct a $400 million drug product plant at its existing facility in Cruiserath.

In January, Novo Nordisk confirmed to us it had acquired land at Grange Castle Business Park and had submitted a planning application, but no further specifics were given. A few months before this, Thermo Fisher Scientific doubled its lab capacity in Ringaskiddy, Cork.

Astellas Pharma also forked out over $350 million to construct a facility in Tralee, Ireland to strengthen its internal supply chain in September 2023.

Furthermore, Eli Lilly announced plans to build a €400+ million ($433 million) greenfield site in Limerick, Ireland in January 2022. The firm then magnified the investment to around $1 billion to further support its biologics ambition in the country in March 2023.

Four months later, Lilly selected ABEC, a solutions and services for biotech manufacturing to support Basis of Design (BOD) engineering of the plant’s upstream and downstream processes at its single-use facility in Limerick.

About the Author(s)

Millie Nelson

Editor, BioProcess Insider

Journalist covering global biopharmaceutical manufacturing and processing news and host of the Voices of Biotech podcast.

I am currently living and working in London but I grew up in Lincolnshire (UK) and studied in Newcastle (UK).

Got a story? Feel free to email me at [email protected]

You May Also Like